SGLT2 Is Tied to Fewer Post-MI Deaths in T2D
Observational registry data from Sweden showed a significant link between SGLT2 inhibitor use at the time of an MI in people with type 2 diabetes and fewer all-cause deaths in 1-year follow-up.
Stay updated with breaking news from Presented August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Observational registry data from Sweden showed a significant link between SGLT2 inhibitor use at the time of an MI in people with type 2 diabetes and fewer all-cause deaths in 1-year follow-up.
Myocardial performance index, a heart-function metric derived from echo findings, significantly boosted the ability to predict incident CVD, especially heart failure, in people with type 1 diabetes.
The guideline task force says STEMI and non-ST elevation ACS represent a spectrum, and after the initial triage and management decisions, most of the remaining care follows a common pathway.
Results of the DANPACE II randomized trial refute the theory that slower pacing can reduce the risk of atrial fibrillation in patients with sinus node dysfunction.
Endocarditis can present with many different clinical scenarios, so making the diagnosis can be challenging, says a co-chair of newly issued European guidelines for managing this disease.